| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |